aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Skyline Vet Pharma is dedicated to developing and marketing superior animal health products. The company focuses on innovative solutions to enhance the well-being of animals, targeting the veterinary pharmaceutical market. Their mission is to provide high-quality, effective treatments that improve animal health and support veterinary professionals.
Skyline Vet Pharma has made significant strides in the animal health industry, gaining recognition for its commitment to quality and innovation. Their products have positively impacted the veterinary field, helping to advance animal care standards. The company's efforts have attracted attention from key stakeholders and investors in the veterinary pharmaceutical sector.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Pharmaceuticals
Technology
Veterinary
Tags
Biotech
Model Types
SaaS
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Skyline Vet Pharma founded?
Skyline Vet Pharma was founded in 2015.
Where is Skyline Vet Pharma’s headquarters located?
Skyline Vet Pharma’s headquarters is located in Providence, US.
When was Skyline Vet Pharma’s last funding round?
Skyline Vet Pharma’s most recent funding round was for $5M (USD) in April 2017.
How many employees does Skyline Vet Pharma have?
Skyline Vet Pharma has 7 employees as of Feb 5, 2024.
How much has Skyline Vet Pharma raised to-date?
As of July 05, 2023, Skyline Vet Pharma has raised a total of $5M (USD) since Apr 13, 2017.
Add Comparison
Total Raised to Date
$5M
USD
Last Update Apr 13, 2017
Last Deal Details
$5M
USD
Apr 13, 2017
Series A
Total Employees Over Time
7
As of Feb 2024
Skyline Vet Pharma Address
10 Dorrance St
suite 700
Providence,
02903
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts